Article PDF
Avoid common mistakes on your manuscript.
References
Chen, W., Hill, H., Christie, A., Kim, M.S., Holloman, E., Pavia-Jimenez, A., Homayoun, F., Ma, Y., Patel, N., Yell, P., Hao, G., Yousuf, Q., Joyce, A., Pedrosa, I., Geiger, H., Zhang, H., Chang, J., Gardner, K.H., Bruick, R.K., Reeves, C., Hwang, T.H., Courtney, K., Frenkel, E., Sun, X., Zojwalla, N., Wong, T., Rizzi, J.P., Wallace, E.M., Josey, J.A., Xie, Y., Xie, X.J., Kapur, P., McKay, R.M., and Brugarolas, J. (2016). Targeting renal cell carcinoma with a HIF-2 antagonist. Nature 539, 112–117.
Cho, H., Du, X., Rizzi, J.P., Liberzon, E., Chakraborty, A.A., Gao, W., Carvo, I., Signoretti, S., Bruick, R.K., Josey, J.A., Wallace, E.M., and Kaelin, W.G. (2016). On-target efficacy of a HIF-2a antagonist in preclinical kidney cancer models. Nature 539, 107–111.
Curtis, S.A., Cohen, J.V., and Kluger, H.M. (2016). Evolving immunotherapy approaches for renal cell carcinoma. Curr Oncol Rep 18, 57.
Errington, W.J., Khan, M.Q., Bueler, S.A., Rubinstein, J.L., Chakrabartty, A., and Privé, G.G. (2012). Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase. Structure 20, 1141–1153.
Guo, Z.Q., Zheng, T., Chen, B., Luo, C., Ouyang, S., Gong, S., Li, J., Mao, L.L., Lian, F., Yang, Y., Huang, Y., Li, L., Lu, J., Zhang, B., Zhou, L., Ding, H., Gao, Z., Zhou, L., Li, G., Zhou, R., Chen, K., Liu, J., Wen, Y., Gong, L., Ke, Y., Yang, S.D., Qiu, X.B., Zhang, N., Ren, J., Zhong, D., Yang, C.G., Liu, J., and Jiang, H. (2016). Small-molecule targeting of E3 ligase adaptor SPOP in kidney cancer. Cancer Cell 30, 474–484.
Jonasch, E., Gao, J., and Rathmell, W.K. (2014). Renal cell carcinoma. BMJ 349, g4797–g4797.
Li, G., Ci, W., Karmakar, S., Chen, K., Dhar, R., Fan, Z., Guo, Z., Zhang, J., Ke, Y., Wang, L., Zhuang, M., Hu, S., Li, X., Zhou, L., Li, X., Calabrese, M.F., Watson, E.R., Prasad, S.M., Rinker-Schaeffer, C., Eggener, S.E., Stricker, T., Tian, Y., Schulman, B.A., Liu, J., and White, K.P. (2014). SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer. Cancer Cell 25, 455–468.
Liu, J., Ghanim, M., Xue, L., Brown, C.D., Iossifov, I., Angeletti, C., Hua, S., Nè gre, N., Ludwig, M., Stricker, T., Al-Ahmadie, H.A., Tretiakova, M., Camp, R.L., Perera-Alberto, M., Rimm, D.L., Xu, T., Rzhetsky, A., and White, K.P. (2009). Analysis of Drosophila segmentation network identifies a JNK pathway factor overexpressed in kidney cancer. Science 323, 1218–1222.
Stone, L. (2016). Kidney cancer: on target-inhibiting SPOP in ccRCC. Nat Rev Urol 13, 630–630.
Zhuang, M., Calabrese, M.F., Liu, J., Waddell, M.B., Nourse, A., Hammel, M., Miller, D.J., Walden, H., Duda, D.M., Seyedin, S.N., Hoggard, T., Harper, J.W., White, K.P., and Schulman, B.A. (2009). Structures of SPOP-substrate complexes: insights into molecular architectures of BTB- Cul3 ubiquitin ligases. Mol Cell 36, 39–50.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Zheng, T., Yang, CG. Targeting SPOP with small molecules provides a novel strategy for kidney cancer therapy. Sci. China Life Sci. 60, 91–93 (2017). https://doi.org/10.1007/s11427-016-0297-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-016-0297-2